en · de · es
sr9009-notes.peptides7501.com › Info › Sr9009 Background And Mechanism — Complete Guide

Sr9009 Background And Mechanism — Complete Guide

By Editorial Desk · published 2026-06-08 · last reviewed 2026-06-29 · Info

research chemical raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-06-29. Anything still debated is marked as such rather than presented as settled.

SR9009 Background and Mechanism

Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.

In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.

Background and Research Status

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small-molecule REV-ERB agonistNot a hormone or natural product
Primary targetsREV-ERBα and REV-ERBβNuclear receptors involved in circadian and metabolic regulation
AppearanceWhite to off-white solidTypical for purified research samples
SolubilitySoluble in DMSO and ethanol; low water solubilityLaboratory solubility depends on solvent and purity
Common synonymsSR9009; StenabolicStenabolic is a colloquial name, not a formal chemical name

Handling Storage and Quality Control

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Related pages on this site

Analytical Detection and Laboratory Handling

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Analytical Detection and Storage

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.

SR9009 Handling and Quality Control

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.

SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.

Supporting material

Cunda Kammāraputta was a smith who gave Gautama Buddha his last meal as an offering while he visited his mango grove in Pāvā on his way to Kuśīnagara. Shortly after having Cunda's meal, the Buddha suffered from fatal dysentery. The condition could have been Clostridial necrotizing enteritis due to a high protein (meat) diet. Before entering the parinirvāṇa, the Buddha told Ānanda to visit Cunda and tell him that his meal had nothing to do with his getting ill, and therefore should feel no blame nor remorse; on the contrary, offering the Tathāgata his last meal before dying was of equal gain as of offering him his first meal before attaining buddhahood, and thus he should rejoice.

methyl Also carbinyl. The alkyl functional group derived from methane, consisting of one carbon atom bonded to three hydrogen atoms, with the chemical formula CH3. It is the simplest hydrocarbon and occurs as a substituent in numerous organic compounds, though it may also exist independently as an ion or radical. In IUPAC nomenclature, the presence of a methyl substituent is indicated with the prefix methyl in the name of the compound, or with the abbreviation Me in chemical formulae; e.g. methyl alcohol (methanol) is often written with the formula CH3OH or MeOH.

The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic consisting of 50 states and a federal capital district, Washington, D.C. The 48 contiguous states border Canada to the north and Mexico to the south, with the semi-exclave of Alaska in the northwest and the archipelago of Hawaii in the Pacific Ocean. The United States also asserts sovereignty over five major island territories and various uninhabited islands in Oceania and the Caribbean. It is a megadiverse country, with the world's fourth-largest total area and third-largest population, exceeding 341 million. Paleo-Indians migrated from North Asia to North America at least 15,000 years ago and formed various civilizations. Beginning in 1607, British colonization established the Thirteen Colonies. The 18th-century American Enlightenment spread values of republicanism and liberalism there, and clashes with the British Crown over taxation without parliamentary representation, among other denied rights, sparked the American Revolution. Independence from Great Britain was formally declared in the Lee Resolution of July 2, 1776, two days before the Declaration of Independence. Victory in the 1775–1783 Revolutionary War brought international recognition of U.S. sovereignty. The U.S. expanded westward through the purchase, settlement, and conquest of European- and Indigenous-controlled territory.

Continuous-wave lasers however are often preferred to pulsed lasers due to the latter's relatively low duty cycle since they can only produce photo ions during the brief later pulses, and the difficulty in reproducing results due to pulse-to-pulse jitters, laser beam drifting, and wavelength variations. Moderate laser powers, if high enough to affect the desired transition states, can be used since the non-resonant photoionization cross section is low which implies a negligible ionization efficiency of unwanted atoms. The influence of the laser matrix to be used for the sample can also be reduced by separating evaporation and ionization processes both in time and in space. Another factor that could affect the efficiency and selectivity of the ionization process is the presence of contaminants caused by surface or impact ionization. This can be reduced up to appreciable orders of magnitude by using mass analysis so that isotopic compositions of the desired element are determined. Most of the elements of the Periodic Table can be ionized by one of the several excitation schemes available. The suitable excitation scheme depends on certain factors including the level scheme of the element's atom, its ionization energy, required selectivity and sensitivity, likely interference, and the wavelengths and power levels of the available laser systems. Most excitation schemes vary in the last step, the ionization step. This is due to the low cross-section for non-resonant photo-ionization produced by the laser.

== External links == International Society for Condensed Matter Nuclear Science (iscmns.org), organizes the ICCF conferences and publishes the Journal of Condensed Matter Nuclear Science. See: library.htm of published papers and proceedings. Low Energy Nuclear Reactions (LENR) Phenomena and Potential Applications Archived 7 October 2015 at the Wayback Machine: Naval Surface Warfare Center report NSWCDD-PN-15-0040 by Louis F. DeChiaro, PhD, 23 September 2015

Sources: en.wikipedia.org

Notes from published material

=== Development === In March 2015, Rajinikanth was reported to have signed his next film with AR Murugadoss and producer V. Ravichandran of Aascar Films; the project was reported to have been out on hold until his issue with the distributors over the financial losses of his film Lingaa (2014) was resolved. The project was never realised due to Ravichandran's bankruptcy. On 25 September 2018, media reported Rajinikanth would collaborate with Murugadoss for his next project and would be financed by Sun Pictures, which produced the latter's Sarkar (2018) and the former's Petta (2019). On 25 November that year, Lyca Productions announced it would collaborate with Rajinikanth and Murugadoss again after their previous collaboration of the former's 2.0 (2018) and the latter's Kaththi (2014) . At an awards ceremony held in December 2018, Murugadoss stated the film was not about politics like some of his previous films but a "mass entertainer". Production of the film began with the working title Thalaivar 167. Composer Anirudh Ravichander and cinematographer Santosh Sivan confirmed their involvement in the film. On 9 April 2019, Lyca Productions released the film's first-look poster on social media platforms, revealing the film's title as Darbar. The first look of Rajinikanth had him surrounded by police dogs, belts, badges and handcuffs. It was Rajinikanth's first role as a police officer after 27 years, his previous police role being in Pandiyan (1992).

==== De-epithelialization technique ==== Labial reduction by means of the de-epithelialization of the tissues involves cutting the epithelium of a central area on the medial and lateral aspects of each labium minus (small lip), either with a scalpel or with a medical laser. This labiaplasty technique reduces the vertical excess tissue, whilst preserving the natural rugosity (corrugated free-edge) of the labia minora, and thus preserves the sensory and erectile characteristics of the labia. Yet, the technical disadvantage of de-epithelialization is that the width of the individual labium might increase if a large area of labial tissue must be de-epithelialized to achieve the labial reduction.

==== Thailand ==== Traditional markets are the dominant preferred venue for grocery shopping in Thailand due to the local preference for fresh food, as well as lower prices and familiarity with shopkeepers.

Powdered alcohol is made by a process called micro-encapsulation. An auxiliary material for a capsule may be any readily water-soluble substance (e.g. carbohydrate such as dextrins (starch hydrolyzate), protein such as gelatin). For powdered alcohol, maltodextrin (a type of dextrin) was chosen. For the process to encapsulate, a method called spray drying was selected. In this process, a mixture of dextrin and the alcoholic drink is subjected to simultaneous spraying and heating. The spraying converts the liquid to small drops (up to several hundred μm (micrometers) in diameter), and the heat causes the hydrous dextrin to form a film. When the film dries, the drop becomes a microcapsule containing a dehydrated alcoholic drink and dextrin. Drying removes about 90% of the water and 10% of the ethanol from the initial liquid. An explanation for this preferential loss of water over volatile organics like ethanol is called "selective diffusion": a carbohydrate (in this case, maltodextrin) film forms during spray-drying on each droplet. The film allows smaller molecules like water to go through, but not larger ones like ethanol. As a result, more water is lost. The film is formed in about 0.1 second from the creation of the droplet by spraying. There is no time for the internal convection in each drop or capsule to occur. The end result of spray-drying is large amounts of microcapsules with the appearance of a powder. This is powdered alcohol. According to Sato's web page, powdered alcohol contains 30.5% ethyl alcohol by volume in the state of powder.

If increased glucagon does not raise blood sugar levels to normal, the adrenal glands release epinephrine. Epinephrine works to also increase gluconeogenesis and glycogenolysis, while also decreasing the use of glucose by organs, protecting the brain's glucose supply. After hypoglycemia has been prolonged, cortisol and growth hormone are released to continue gluconeogenesis and glycogenolysis, while also preventing the use of glucose by other organs. The effects of cortisol and growth hormone are far less effective than epinephrine. In a state of hypoglycemia, the brain also signals a sense of hunger and drives the person to eat, in an attempt to increase glucose.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.

How does SR9009 work?

It binds REV-ERBα and REV-ERBβ and changes transcription of metabolic genes. This can affect circadian rhythm, lipid use, and mitochondrial function. The full downstream effects are still under study.

Is SR9009 proven to improve human performance?

No. Some rodent studies show increased endurance, but controlled human trials are lacking. Claims about human performance are not established by published evidence.

What is SR9009?

It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.

Network